Interaction between terbinafine and warfarin

Dermatology

Volumn 196, Issue 2, 1998, Pages 266-267

  Gupta, Aditya K ^a,c   Ross, G S ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Tidewater Phys Multispecialty Group   (United States)

^c NONE   (Canada)

Author keywords

Drug drug interaction; Gastrointestinal bleeding; Terbinafine; Warfarin

Indexed keywords

CIMETIDINE; TERBINAFINE; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; ANTIFUNGAL AGENTS; DRUG INTERACTIONS; FEMALE; GASTROINTESTINAL DISEASES; HEMORRHAGE; HUMANS; NAPHTHALENES; ONYCHOMYCOSIS; THROMBOSIS; WARFARIN;

EID: 0031932106     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017890     Document Type: Article

References (8)

1. Terbinafine hydrochloride (Lamisil®) product monograph. Sandoz Pharmaceutical s Corporation, East Hanover, New Jersey, USA, April 1996.
2. O'SuIIivan DP, Needham CA, Bangs A, Atkin K, Kendall FD: Post-marketing surveillance of oral terbinafine in the UK: Report of a large cohort study. Br J Clin Pharmacol 1976;42: 559-565.
3. Kaminsky LS, Dunbar DA, Wang PP. Beaune P, Lawey D, Guengerich FP, Schnellmann RG, Sipes IG: Human heptic cytochrome P-450 composition as probed by in vitro microsomal metabolism of warfarin. Drug Metab Dispos 1984;12: 470-477.
4. Toon S, Low LK, Gibaldi M, Trager WF, O'Reilly RA, Motley CH, Goulart DA: The warfarin/sulfinpyrazone interaction: Stereochemical considerations. Clin Pharmacol Ther 1986;39:15-24.
5. Slaughter RL, Edwards DJ: Recent advances: The cytochrome P-450 enzymes. Ann Pharmacother l995;29:619-624.
6. Brøsen K: Drug interactions and the cytochrome P-450 system: The role of cytochrome P-450 1A2. Clin Pharmacokinet 1995;29 (suppl l):20-25.
7. Choonara IA, Cholerton S, Haynes BP, Breckenridge AM, Park BK: Stereoselective interaction between R enantiomer of warfarin and cimetidine. Br J Clin Pharmacol 1986;21:271-277.
8. Weintraub M, Breckenridge RT, Griner PF: The effects of dextrothyroxine on the kinetics of prothrombin activity: Proposed mechanism of the potentiation of warfarin by D-thyroxine. J Lab Clin Med 1973;81:273-279.